178 related articles for article (PubMed ID: 20950578)
1. [The use of passive rabies immunotherapy: from the past to the future].
Bourhy H; Dacheux L; Ribadeau-Dumas F
Biol Aujourdhui; 2010; 204(1):71-80. PubMed ID: 20950578
[TBL] [Abstract][Full Text] [Related]
2. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
Koprowski H
Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
[TBL] [Abstract][Full Text] [Related]
4. [Human rabies in France in 2004: update and management].
Peigue-Lafeuille H; Bourhy H; Abiteboul D; Astoul J; Cliquet F; Goudal M; Lerasle S; Mailles A; Montagne MC; Morer I; Rotivel Y; Floret D
Med Mal Infect; 2004 Dec; 34(12):551-60. PubMed ID: 15603930
[TBL] [Abstract][Full Text] [Related]
5. Post exposure human-prophylaxis for rabies in developing countries.
Onyemelukwe GC
Afr J Med Med Sci; 1992 Dec; 21(2):1-12. PubMed ID: 1308073
[No Abstract] [Full Text] [Related]
6. Rabies and post-exposure rabies prophylaxis in Canada, 1987-1988.
Varughese PV; Carter AO
Can Dis Wkly Rep; 1990 Jul; 16(28):131-6. PubMed ID: 2397528
[No Abstract] [Full Text] [Related]
7. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
Lu J; Guo Z; Pan X; Wang G; Zhang D; Li Y; Tan B; Ouyang L; Yu X
Respir Res; 2006 Mar; 7(1):43. PubMed ID: 16553963
[TBL] [Abstract][Full Text] [Related]
8. Rabbit anti-rabies immunoglobulins production and evaluation.
Liu X; Liu Q; Feng X; Tang Q; Wang Z; Li S; Feng Z; Zhu J; Guan X
Trop Biomed; 2011 Apr; 28(1):138-48. PubMed ID: 21602780
[TBL] [Abstract][Full Text] [Related]
9. Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies.
Muhamuda K; Madhusudana SN; Ravi V
Hum Vaccin; 2007; 3(5):192-5. PubMed ID: 17637573
[TBL] [Abstract][Full Text] [Related]
10. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.
Goudsmit J; Marissen WE; Weldon WC; Niezgoda M; Hanlon CA; Rice AB; Kruif Jd; Dietzschold B; Bakker AB; Rupprecht CE
J Infect Dis; 2006 Mar; 193(6):796-801. PubMed ID: 16479514
[TBL] [Abstract][Full Text] [Related]
11. New method to produce equine antirabies immunoglobulin F(ab')₂ fragments from crude plasma in high quality and yield.
Kittipongwarakarn S; Hawe A; Tantipolphan R; Limsuwun K; Khomvilai S; Puttipipatkhachorn S; Jiskoot W
Eur J Pharm Biopharm; 2011 Jun; 78(2):189-95. PubMed ID: 21414404
[TBL] [Abstract][Full Text] [Related]
12. [10 years' of production and use of human rabies immunoglobulin in Yugoslavia].
Romić M; Tomović O; Medić P; Pelević S; Sindić M; Popović M; Gligorović V; Bogdanović G; Mitrović M; Petrović M; Stankov S; Lazarević-Ivanc L; Lalosević V; Lalosević D
Med Pregl; 2001; 54 Suppl 1():33-7. PubMed ID: 12078125
[TBL] [Abstract][Full Text] [Related]
13. From brain passage to cell adaptation: the road of human rabies vaccine development.
Wu X; Smith TG; Rupprecht CE
Expert Rev Vaccines; 2011 Nov; 10(11):1597-608. PubMed ID: 22043958
[TBL] [Abstract][Full Text] [Related]
14. [Rabies].
Ribadeau-Dumas F; Dacheux L; Bourhy H
Med Sci (Paris); 2013 Jan; 29(1):47-55. PubMed ID: 23351694
[TBL] [Abstract][Full Text] [Related]
15. Ovine anti-rabies antibody production and evaluation.
Redwan el-RM; Fahmy A; El Hanafy A; Abd El-Baky N; Sallam SM
Comp Immunol Microbiol Infect Dis; 2009 Jan; 32(1):9-19. PubMed ID: 18242705
[TBL] [Abstract][Full Text] [Related]
16. Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin.
Wilde H; Chomchey P; Punyaratabandhu P; Phanupak P; Chutivongse S
Bull World Health Organ; 1989; 67(6):731-6. PubMed ID: 2633888
[TBL] [Abstract][Full Text] [Related]
17. Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe?
Bourhy H; Goudal M; Mailles A; Sadkowska-Todys M; Dacheux L; Zeller H
Euro Surveill; 2009 Apr; 14(13):. PubMed ID: 19341608
[TBL] [Abstract][Full Text] [Related]
18. Overview, prevention, and treatment of rabies.
Nigg AJ; Walker PL
Pharmacotherapy; 2009 Oct; 29(10):1182-95. PubMed ID: 19792992
[TBL] [Abstract][Full Text] [Related]
19. Rabies vaccinology and immunology.
Wandeler AI
Dev Biol (Basel); 2006; 125():181-4. PubMed ID: 16878475
[No Abstract] [Full Text] [Related]
20. Postexposure rabies prophylaxis completed in 1 week: preliminary study.
Shantavasinkul P; Tantawichien T; Wilde H; Sawangvaree A; Kumchat A; Ruksaket N; Lohsoonthorn V; Khawplod P; Tantawichien T
Clin Infect Dis; 2010 Jan; 50(1):56-60. PubMed ID: 19995217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
